SGLT2 inhibitor initiation in patients hospitalized for acute heart failure: does it still matter when patients are strictly followed after discharge?

Back

HFA Premium Access

SGLT2 inhibitor initiation in patients hospitalized for acute heart failure: does it still matter when patients are strictly followed after discharge?

Session: Heart Failure ePosters - focus on Chronic Heart Failure 4

Topic: Pharmacotherapy

Speaker: Doctor B. Silva (Lisbon, PT)

Event: Heart Failure 2022

Congress Presentation

Add to my library

About the speaker

Doctor Beatriz Valente Silva

CHULN and Faculty of medicine of the University of Lisbon, Lisbon (Portugal)

0 follower

37 more presentations in this session

Quadruple therapy with ARNI vs quadruple therapy with ACEI on cardiovascular outcomes for heart failure with reduced ejection fraction: a network meta-analysis

Speaker: Doctor J. Diaz Acevedo (Dalton, US)

Access

Abstract

Slides

Position and cardiorenal mechanisms of uromodulin in heart failure

Speaker: Doctor L. Emmens (Groningen, NL)

Access

Abstract

Slides

Bridge to cardiac transplantation with temporary mechanical circulatory support: trends and outcomes in Spain (2010-2020)

Speaker: Doctor E. Barge Caballero (A Coruna, ES)

Access

Abstract

Slides

Hepatic T1-time is a strong and independent predictor of cardiovascular outcome in all-comers referred for cardiac magnetic resonance imaging

Speaker: Doctor K. Mascherbauer (Vienna, AT)

Access

Abstract

Slides

Virtual management of HF outpatient during COVID-19 pandemic period: a comparison with traditional follow up

Speaker: Doctor S. Prosperi (Rome, IT)

Access

Abstract

Slides

Access the full session

Heart Failure ePosters - focus on Chronic Heart Failure 4

Speakers: Doctor B. Silva, Doctor J. Diaz Acevedo, Doctor L. Emmens, Doctor E. Barge Caballero, Doctor K. Mascherbauer...

Access

About the event

Heart Failure 2022

21 May - 24 May 2022

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources